Séverine Vermeire - Concepedia

Author

Séverine Vermeire

Also Known As

Abreu, M.T., Annika Bergquist, Bram Verstockt, C.A. Anderson, Dan Turner, Erik Schrumpf, Harry Sokol, João Sabino, K W A van Dongen, LOVE-UC study group

2.4K

Publications

109.8K

Citations

163

H-Index

211

Concepts

All Affiliations

KU Leuven Universitair Ziekenhuis Leuven University of California San Diego University of Liège Icahn School of Medicine at Mount Sinai

About

Séverine Vermeire is an author at KU Leuven specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	75	204	28.3K
2	Public Health	17	22	4.8K
3	Allergy	12	14	1.4K
4	Health Sciences	2	2	39
5	Biochemistry	1	1	45

Séverine Vermeire

602

Publications

78.3K

Citations

145

H-Index

Page 1

	Year	Citations
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Mark S. Silverberg, Jack Satsangi, Tariq Ahmad, Canadian Journal of Gastroenterology	2005	3.3K
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease Filip Baert, Maja Noman, Séverine Vermeire, New England Journal of Medicine	2003	2K
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis Kathleen Machiels, Marie Joossens, João Sabino, Gut	2013	1.8K
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease Brian G. Feagan, William J. Sandborn, Christopher Gasink, New England Journal of Medicine	2016	1.7K
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis William J. Sandborn, Chinyu Su, Bruce E. Sands, New England Journal of Medicine	2017	1.7K
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management James O. Lindsay, Andreas Sturm, Alastair Windsor, Journal of Crohn s and Colitis GastroenterologyDiagnosisClinical SpecialtiesSevere UcSurgery	2012	1.5K
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Geert D’Haens, Filip Baert, Gert Van Assche, The Lancet Autoimmune DiseaseImmunosuppressive TherapyImmunologyGastroenterologyClinical Gastroenterology	2008	1.2K
Quantitative microbiome profiling links gut community variation to microbial load Doris Vandeputte, Gunter Kathagen, Kevin D’hoe, Nature Microbial DiversityDysbiosisMicrobiotaGut MicrobiologyQuantitative Microbiome	2017	1.1K
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease Gert Van Assche, Marc Van Ranst, Raf Sciot, New England Journal of Medicine Rheumatoid DisorderAutoimmune DiseaseMedicineImmunodeficienciesImmunology	2005	1.1K
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives Marie Joossens, Geert Huys, Margo Cnockaert, Gut	2011	1K

Page 1